PM
CLB icon

Penbrook Management’s Core Laboratories CLB Stock Holding History

Penbrook Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,428
Closed -$289K – 103
2021
Q2 		$289K Hold
7,428
– – 0.17% 93
2021
Q1 		$214K Buy
+7,428
New +$254K 0.15% 95
2020
Q1 		– Sell
-7,188
Closed -$271K – 104
2019
Q4 		$271K Sell
7,188
-60
-0.8% -$2.7K 0.26% 91
2019
Q3 		$338K Hold
7,248
– – 0.37% 78
2019
Q2 		$379K Hold
7,248
– – 0.41% 76
2019
Q1 		$500K Sell
7,248
-440
-6% -$29.5K 0.52% 67
2018
Q4 		$459K Sell
7,688
-60
-0.8% -$5.18K 0.52% 61
2018
Q3 		$897K Sell
7,748
-2,560
-25% -$289K 0.86% 39
2018
Q2 		$1.3M Sell
10,308
-260
-2% -$31.6K 1.25% 27
2018
Q1 		$1.14M Sell
10,568
-520
-5% -$57.5K 1.14% 30
2017
Q4 		$1.22M Buy
+11,088
New +$1.11M 1.09% 26
2016
Q3 		$1.29M Hold
11,488
– – 1.39% 21
2016
Q2 		$1.42M Sell
11,488
-200
-2% -$24.1K 1.57% 14
2016
Q1 		$1.31M Hold
11,688
– – 1.45% 19
2015
Q4 		$1.27M Hold
11,688
– – 1.3% 26
2015
Q3 		$1.17M Sell
11,688
-270
-2% -$29.4K 1.24% 29
2015
Q2 		$1.36M Hold
11,958
– – 1.29% 29
2015
Q1 		$1.25M Hold
11,958
– – 1.11% 33
2014
Q4 		$1.44M Hold
11,958
– – 1.3% 27
2014
Q3 		$1.75M Hold
11,958
– – 1.61% 14
2014
Q2 		$2M Sell
11,958
-150
-1% -$26.7K 1.76% 10
2014
Q1 		$2.4M Sell
12,108
-100
-0.8% -$18.9K 2.27% 5
2013
Q4 		$2.33M Buy
+12,208
New +$2.27M 2.26% 8

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Penbrook Management's CLB Position: Q3 2021 in Review

Penbrook Management sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 7,428 shares — an estimated $289K sold.

Penbrook Management first reported a position in CLB in Q4 2013 and held it in 23 quarters. The position peaked at $2.4M in Q1 2014. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Penbrook Management reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Penbrook Management sold 7,428 Core Laboratories shares in Q3 2021, an estimated $289K.
  • Penbrook Management first reported a position in Core Laboratories in Q4 2013 and held it in 23 quarters.
  • Penbrook Management's Core Laboratories position peaked at $2.4M in Q1 2014.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Penbrook Management's 13F filing for Q3 2021, filed 26 Oct 2021.